Diet, High-FatFACTNCT04743271
Food and Circadian Timing
A study testing High-Fat Diet and Low-Fat Diet in people with Diet, High-Fat and Circadian Rhythm, run by Oregon Health and Science University at 1 site in United States.
Trial summary
The goals of this study are to uncover the influence of diet on the human circadian timing system. The protocol is a 46-day (28 outpatient days, 18 inpatient days over two 9 day visits) randomized cross-over study designed to elucidate the speed of entrainment in response to a high-fat diet. Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Diet, High-Fat, Circadian Rhythm
- What is being tested?
- High-Fat Diet and Low-Fat Diet
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 14 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Apr 2022to 31 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy, lean men and women
Who cannot join
- Major dietary restrictions (such as entirely dairy-free and/or meat-free diets)
- A body mass index (BMI) of 18.5< [BMI] < 24.9 kg/m^2 and a waist circumference <94/80cm
- Currently psychiatrically/psychologically unsuitable for participation
- Drug/alcohol use, including smoking
- Medication/drug use, including prescribed and over-the-counter medications
- History of working irregular day and night hours, regular night work, or rotating shift work for the 1 year prior to the study.
Show all 27Show fewer
- Traveled across more than 1 time zone during the 3 months prior to the study
- Currently consuming a habitual high-fat diet
- Chronobiologic and sleep disorders
- Diseases of the Cardiovascular System
- Metabolic Syndrome; Two or more of these factors will be excluded from the study:
- HDL cholesterol of less than 40 mg/dL in men or less than 50 mg/dL in women;
- systolic blood pressure>135 mmHg or diastolic blood pressure>85 mmHg;
- Fasting blood glucose ≥ 100 mg/dL;
- Triglycerides ≥ 150 mg/dL.
- Pre-Diabetes/Diabetes
- Hypertension
- Disorders of the Respiratory System
- Disorders of the Kidney and Urinary Tract
- Infectious Diseases
- Disorders of the Gastrointestinal System
- Disorders of the Immune System
- Disorders of the Hematopoietic System
- Neoplastic Diseases
- Endocrine and Metabolic Diseases
- Neurologic Disorders
- Subjects must not be currently participating in another research study that would influence their safe participation in our study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Oregon Health & Science University
Portland, Oregon, 97239
Andrew W McHill, PhD, 5034942594, mchill@ohsu.edu
About this study
Official title: Uncovering the Impact of Diet on the Human Circadian Timing System
The goals of this study are to uncover the influence of diet on the human circadian timing system. The protocol is a 46-day (28 outpatient days, 18 inpatient days over two 9 day visits) randomized cross-over study designed to elucidate the speed of entrainment in response to a high-fat diet.
Read the detailed description
Synchronization of the timing of biological processes and behaviors with the 24-hour light-dark cycle is fundamental to almost every physiological process, cognitive function, and overall health. As the average circadian period in humans is ~9 min longer than the 24-h day, and artificial lighting allows a further delay in the clock, circadian entrainment must occur every day. This makes the process of circadian entrainment of the internal clock with the external environment a commonly overlooked process, but one that has serious ramifications if impaired.
In rodent models, high-fat diets have been shown to disorganize the circadian timing system. There has been limited examination, however, of how composition of diet acts on the circadian timing system in humans. The ability to entrain to a new light schedule has been briefly examined after a high-fat diet in rodent models.When mice are exposed to a 6-h shift in the light-dark cycle and fed a diet composed of ~50% fat for 3 weeks, they experience a 20% slower rate of re-entrainment to the new light cycle as compared to mice fed a low-fat diet. Further, these mice had an attenuated response to a phase-advancing light pulse. Moreover, simply providing a high-fat diet to mice results in a lengthened circadian period and a shift in ad libitum eating patterns into the typical rest phase.
The goals of this study are to uncover the influence of diet on the human circadian timing system. The protocol is a 46-day (28 outpatient days, 18 inpatient days over two 9 day visits) randomized cross-over study designed to elucidate the speed of entrainment in response to a high-fat diet. Participants will be provided 3 weeks of a high-fat diet (2-weeks outpatient, 1-week inpatient) of 50% calories from fat. The protocol includes two types of data collection; ambulatory monitoring on strict sleep-wake schedules with either high-fat or low-fat meals provided by the study team and precise in-laboratory measurements of circadian timing, entrainment, and other physiological markers of sleep and cardiometabolic health.
- Ambulatory Monitoring: Participants will maintain a consistent 14-day at home 8h sleep schedule at habitual times before both laboratory visits to ensure 1) subjects are not sleep restricted and 2) that they are obtaining the same light-dark schedule prior to each laboratory visit for stable entrainment; verified by actigraphy, sleep logs, and call-ins to a time stamped recorder. Drugs, medications, caffeine, alcohol, and nicotine will be proscribed during this time and toxicology analysis will be performed upon in-laboratory admission.
- Outpatient diet: For 2-weeks prior to each protocol, participants will consume an outpatient isocaloric diet designed to meet individual daily energy requirements; diet designed and prepared by investigators. Diets will either be designed to be high in calories from fat (50% fat, 35% carbohydrate and 15% protein; 33% of each mono, poly and saturated fat) or low-fat (30% fat, 55% carbohydrate and 15% protein) (randomized-crossover design). The diet will consist of a breakfast, lunch, dinner, and snack and participants will either come to the laboratory ~3 days or staff will deliver meals. Participants will be instructed to only consume the food provided during these 14-days. Adherence to the diet will be captured via tracking meals using a mobile food tracking application (MealLogger AppTM (Wellness Foundry, New York)).
- Inpatient Protocols: Participants will be admitted to an individual room free of external time cues (e.g., clocks, radios, computers, visitors and sunlight). Room temperature is maintained at 21 - 22.2 °C and light intensity set at ≤5 lux during scheduled constant posture procedures, room light (400 lux) during entrainment wakefulness and 0 lux (darkness) during scheduled sleep opportunities. Participants will be instrumented for full polysomnography (PSG), electrocardiogram, and a rectal thermistor for continuous core body temperature measurement. An 18-gauge IV catheter will also be inserted into the forearm and connected to a triple-stopcock manifold via an IV loop with a 12- foot small-lumen extension cable through which blood sampling can continue in the next room without disturbing sleep.
After instrumentation, participants will be given a sleep opportunity and will awakened to dim-lighting and maintaining a constant posture protocol for accurate assessment of circadian phase, resting metabolic rate, and other physiological outcomes. After the constant posture protocol, participants' light-dark cycle will be changed for 6 identical days, followed by a second constant posture protocol for re-assessment of circadian phase. This protocol will be repeated while participants are provided the other cross-over meal. Investigators/nurses will be present in the lab or in a central control room 24 h per day to monitor subject health, data acquisition, provide meals, collect biologic specimens, perform tests, and record sleep. A physician is always on call when a participant is in the laboratory. An extensive series of protocols and checklists and team practices are used to ensure uniformity in execution of standard procedures.
Energy content of diets will be designed to meet individual daily energy requirements. Dietitians will prepare isocaloric meals containing macronutrient contents of high or low-fat diet and no caffeine. Caloric intake will be the same caloric and macronutrient composition for each day of laboratory study and will be provided as miniature snacks frequently during each constant posture protocol (e.g., ¼ turkey \& cheese sandwich, juice and water).
- Conditions
- Diet, High-Fat, Circadian Rhythm
- Being tested
- High-Fat Diet, Low-Fat Diet
- Keywords
- Circadian Rhythm, High Fat, Diet
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High-Fat DietOther
The diet will consist of a breakfast, lunch, dinner, and snack
Low-Fat DietOther
The diet will consist of a breakfast, lunch, dinner, and snack
| Study group | Role | What they receive |
|---|---|---|
| High-Fat Diet | Experimental | 50% fat, 35% carbohydrate and 15% protein; 33% of each mono, poly and saturated fat Receives: Other: High-Fat Diet |
| Low-Fat Diet | Active comparator | 30% fat, 55% carbohydrate and 15% protein Receives: Other: Low-Fat Diet |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Speed of entrainment
Entrainment will be determined as a stable phase angle between sleep and both melatonin onset. Blood and/or saliva will be assayed for melatonin using standardized assays. Melatonin onset will be calculated using the linear interpolated time at which melatonin levels reach 25% of a fitted peak-to-trough amplitude. This will be analyzed using phase angle between sleep and melatonin onset.
Measured: Over 18 days
Secondary outcomes (20)
Change in Phase Angle of entrainment
Phase angle will be calculated as dim-light melatonin onset minus sleep onset during each constant posture protocol. Differences in phase angle of entrainment between sleep and melatonin onset will be first examined using planned comparison dependent t-tests between the high-fat and low-fat visits. The study will use planned comparison dependent t-tests to compare phase angle of entrainment from constant posture day 1 vs constant posture day 2 to uncover potential differences in phase angle in response to an advance in light exposure under differing diet conditions
Measured: Over 18 days
Change in Core Body Temperature Entrainment
Core body temperature entrainment will be determined as a stable phase angle between sleep and core body temperature minimum. Temperature data will be collected every minute though rectal thermistors.
Measured: Over 18 days
Change in Core Body Temperature Phase angle of Entrainment
Core body temperature entrainment will be determined as core body temperature minimum minus sleep onset. Temperature data will be collected every minute though rectal thermistors.
Measured: Over 18 days
Change in glucose tolerance
The participant's glucose and insulin response to a mixed meal diet high in carbohydrates may be tested. During this mixed meal test, a baseline blood draw will occur ~7-min before the meal and then the frequency of blood samples will increase to every 10-min after the meal for 90 min and then every 30 min for 90 min for a total of 12 samples over 180 min to measure glucose and hormone response in detail. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Energy Metabolism
Resting energy metabolism will be measured every ~4h via indirect calorimetry. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Blood Pressure
Resting blood pressure will be measured every ~2h via blood pressure cuff. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Heart Rate
Resting heart rate will be measured every ~2h via blood pressure cuff. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Malondialdehyde
Malondialdehyde will be measured every ~4h via blood from IV catheter. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Total Antioxidant Capacity
Total Antioxidant Capacity will be measured every ~4h via blood from IV catheter. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in C-reactive protein
C-reactive protein will be measured every ~4h via blood from IV catheter. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in TNF-alpha
TNF-alpha will be measured every ~4h via blood from IV catheter. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Triglycerides
Triglycerides will be measured every ~4h via blood from IV catheter. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Fatty Acids
Fatty acids will be measured every glucose tolerance test from IV catheter. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Vascular Endothelial Function
We will measure vascular endothelial function starting ~10-min after each awakening in a constant posture following a fast. Brachial artery flow-mediated dilation will be measured in the supine position. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Psychomotor Vigilance Task
The psychomotor vigilance task will be administered via computer test every 2h to assess sustained attention. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Digit Symbol Substitution Task
The digit symbol substitution task will be administered via computer test every 2h to assess attention and accuracy. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Addition Task
The addition task will be administered via computer test every 2h to assess working memory. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Subjective Alertness
Visual analog scales will be administered via computer test every 2h to subjective alertness. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Profile of Mood States
Profile of mood states (POMS scale) will be administered via paper questionnaire every 2h to subjective alertness. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Change in Positive and Negative Affect Schedule
Positive and negative affect schedule (PANAS scale) will be administered via paper questionnaire every 2h to subjective alertness. Examined using planned comparison dependent t-tests between the high-fat and low-fat visits.
Measured: Over 18 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2021
- Study start1 Apr 2022
- Primary completion31 Mar 2027 (estimated)
- Study completion31 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diet, High-FatStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 14 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Oregon Health and Science University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institutes of Health (NIH)
- Responsible party
- Principal investigator, Andrew McHill, Oregon Health and Science University
- Investigators
- Andrew McHill, PhD, Principal investigator, Oregon Health and Science University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04743271
- Sponsor's protocol ID
- STUDY00022478
- Acronym
- FACT
- Status last verified
- Oct 2026
- First submitted
- 28 Jan 2021
- Last updated
- 16 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Uncovering the Impact of Diet on the Human Circadian Timing System
- ClinicalTrials.gov ID
- NCT04743271
- Acronym / sponsor ID
- FACT / STUDY00022478
- Conditions
- Diet, High-Fat, Circadian Rhythm
- Keywords
- Circadian Rhythm, High Fat, Diet
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 14 participants (estimated)
- Lead sponsor
- Oregon Health and Science UniversityUniversity, hospital or other
- Collaborators
- National Institutes of Health (NIH)
- Study start
- 1 Apr 2022 (actual)
- Primary completion
- 31 Mar 2027 (estimated)
- Study completion
- 31 Mar 2027 (estimated)
- First posted
- 8 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goals of this study are to uncover the influence of diet on the human circadian timing system. The protocol is a 46-day (28 outpatient days, 18 inpatient days over two 9 day visits) randomized cross-over study designed to elucidate the speed of entrainment in response to a high-fat diet.
Detailed description
Synchronization of the timing of biological processes and behaviors with the 24-hour light-dark cycle is fundamental to almost every physiological process, cognitive function, and overall health. As the average circadian period in humans is ~9 min longer than the 24-h day, and artificial lighting allows a further delay in the clock, circadian entrainment must occur every day. This makes the process of circadian entrainment of the internal clock with the external environment a commonly overlooked process, but one that has serious ramifications if impaired.
In rodent models, high-fat diets have been shown to disorganize the circadian timing system. There has been limited examination, however, of how composition of diet acts on the circadian timing system in humans. The ability to entrain to a new light schedule has been briefly examined after a high-fat diet in rodent models.When mice are exposed to a 6-h shift in the light-dark cycle and fed a diet composed of ~50% fat for 3 weeks, they experience a 20% slower rate of re-entrainment to the new light cycle as compared to mice fed a low-fat diet. Further, these mice had an attenuated response to a phase-advancing light pulse. Moreover, simply providing a high-fat diet to mice results in a lengthened circadian period and a shift in ad libitum eating patterns into the typical rest phase.
The goals of this study are to uncover the influence of diet on the human circadian timing system. The protocol is a 46-day (28 outpatient days, 18 inpatient days over two 9 day visits) randomized cross-over study designed to elucidate the speed of entrainment in response to a high-fat diet. Participants will be provided 3 weeks of a high-fat diet (2-weeks outpatient, 1-week inpatient) of 50% calories from fat. The protocol includes two types of data collection; ambulatory monitoring on strict sleep-wake schedules with either high-fat or low-fat meals provided by the study team and precise in-laboratory measurements of circadian timing, entrainment, and other physiological markers of sleep and cardiometabolic health.
- Ambulatory Monitoring: Participants will maintain a consistent 14-day at home 8h sleep schedule at habitual times before both laboratory visits to ensure 1) subjects are not sleep restricted and 2) that they are obtaining the same light-dark schedule prior to each laboratory visit for stable entrainment; verified by actigraphy, sleep logs, and call-ins to a time stamped recorder. Drugs, medications, caffeine, alcohol, and nicotine will be proscribed during this time and toxicology analysis will be performed upon in-laboratory admission.
- Outpatient diet: For 2-weeks prior to each protocol, participants will consume an outpatient isocaloric diet designed to meet individual daily energy requirements; diet designed and prepared by investigators. Diets will either be designed to be high in calories from fat (50% fat, 35% carbohydrate and 15% protein; 33% of each mono, poly and saturated fat) or low-fat (30% fat, 55% carbohydrate and 15% protein) (randomized-crossover design). The diet will consist of a breakfast, lunch, dinner, and snack and participants will either come to the laboratory ~3 days or staff will deliver meals. Participants will be instructed to only consume the food provided during these 14-days. Adherence to the diet will be captured via tracking meals using a mobile food tracking application (MealLogger AppTM (Wellness Foundry, New York)).
- Inpatient Protocols: Participants will be admitted to an individual room free of external time cues (e.g., clocks, radios, computers, visitors and sunlight). Room temperature is maintained at 21 - 22.2 °C and light intensity set at ≤5 lux during scheduled constant posture procedures, room light (400 lux) during entrainment wakefulness and 0 lux (darkness) during scheduled sleep opportunities. Participants will be instrumented for full polysomnography (PSG), electrocardiogram, and a rectal thermistor for continuous core body temperature measurement. An 18-gauge IV catheter will also be inserted into the forearm and connected to a triple-stopcock manifold via an IV loop with a 12- foot small-lumen extension cable through which blood sampling can continue in the next room without disturbing sleep.
After instrumentation, participants will be given a sleep opportunity and will awakened to dim-lighting and maintaining a constant posture protocol for accurate assessment of circadian phase, resting metabolic rate, and other physiological outcomes. After the constant posture protocol, participants' light-dark cycle will be changed for 6 identical days, followed by a second constant posture protocol for re-assessment of circadian phase. This protocol will be repeated while participants are provided the other cross-over meal. Investigators/nurses will be present in the lab or in a central control room 24 h per day to monitor subject health, data acquisition, provide meals, collect biologic specimens, perform tests, and record sleep. A physician is always on call when a participant is in the laboratory. An extensive series of protocols and checklists and team practices are used to ensure uniformity in execution of standard procedures.
Energy content of diets will be designed to meet individual daily energy requirements. Dietitians will prepare isocaloric meals containing macronutrient contents of high or low-fat diet and no caffeine. Caloric intake will be the same caloric and macronutrient composition for each day of laboratory study and will be provided as miniature snacks frequently during each constant posture protocol (e.g., ¼ turkey \& cheese sandwich, juice and water).
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| High-Fat Diet | Experimental | Other: High-Fat Diet50% fat, 35% carbohydrate and 15% protein; 33% of each mono, poly and saturated fat |
| Low-Fat Diet | Active comparator | Other: Low-Fat Diet30% fat, 55% carbohydrate and 15% protein |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Healthy, lean men and women
Key exclusion criteria (27 listed)
- Major dietary restrictions (such as entirely dairy-free and/or meat-free diets)
- A body mass index (BMI) of 18.5< [BMI] < 24.9 kg/m^2 and a waist circumference <94/80cm
- Currently psychiatrically/psychologically unsuitable for participation
- Drug/alcohol use, including smoking
- Medication/drug use, including prescribed and over-the-counter medications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High-Fat DietThe diet will consist of a breakfast, lunch, dinner, and snack | Other | High-Fat Diet |
| Low-Fat DietThe diet will consist of a breakfast, lunch, dinner, and snack | Other | Low-Fat Diet |
Primary outcome
Change in Speed of entrainment
Time frame: Over 18 days
Entrainment will be determined as a stable phase angle between sleep and both melatonin onset. Blood and/or saliva will be assayed for melatonin using standardized assays. Melatonin onset will be calculated using the linear interpolated time at which melatonin levels reach 25% of a fitted peak-to-trough amplitude. This will be analyzed using phase angle between sleep and melatonin onset.
20 secondary outcomes
Change in Phase Angle of entrainment
Time frame: Over 18 days
Change in Core Body Temperature Entrainment
Time frame: Over 18 days
Change in Core Body Temperature Phase angle of Entrainment
Time frame: Over 18 days
Change in glucose tolerance
Time frame: Over 18 days
Change in Energy Metabolism
Time frame: Over 18 days
Change in Blood Pressure
Time frame: Over 18 days
Change in Heart Rate
Time frame: Over 18 days
Change in Malondialdehyde
Time frame: Over 18 days
Change in Total Antioxidant Capacity
Time frame: Over 18 days
Change in C-reactive protein
Time frame: Over 18 days
Change in TNF-alpha
Time frame: Over 18 days
Change in Triglycerides
Time frame: Over 18 days
Change in Fatty Acids
Time frame: Over 18 days
Change in Vascular Endothelial Function
Time frame: Over 18 days
Change in Psychomotor Vigilance Task
Time frame: Over 18 days
Change in Digit Symbol Substitution Task
Time frame: Over 18 days
Change in Addition Task
Time frame: Over 18 days
Change in Subjective Alertness
Time frame: Over 18 days
Change in Profile of Mood States
Time frame: Over 18 days
Change in Positive and Negative Affect Schedule
Time frame: Over 18 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Diet, High-Fat
Active, not recruiting
Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance
Obesity (Body Mass Index >30 kg/m2)
Active, not recruiting
Ultra-high-caloric, Fatty Diet in ALS
Amyotrophic Lateral Sclerosis
Active, not recruiting
Dietary Strategies for Remission of Type 2 Diabetes
Diabetes Mellitus, Type 2, Overweight and Obesity
Not yet recruiting
Comparing Two Low-Carbohydrate Diets With a Standard Diet in Type 2 Diabetes
Diabete Mellitus, Obesity & Overweight
Recruiting
Defining the Human Insulin Resistance Molecular Network; SIGNATURE
Metabolic Health, Insulin Sensitivity/Resistance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Andrew McHill, PhD principal investigator
Oregon Health and Science University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High-Fat Diet and Low-Fat Diet in people with Diet, High-Fat and Circadian Rhythm, run by Oregon Health and Science University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 27 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Andrew McHill, PhD (503-494-2594, mchill@ohsu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Speed of entrainment (time frame: Over 18 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.